We observed a similarly significant trend in an independent set of 172 GBM samples from the Chinese Glioma Genome Atlas (CGGA) project (Wang et al, 2015; Liu et al, 2018), where low MYBL2 levels correspond to higher survival only in the Proneural subtype (log‐rank test P = 0.028, Figs 5G and EV4D). The gene discussed is MYBL2; the disease is central nervous system cancer.